Literature DB >> 3195435

Left ventricular topographic alterations in the completely healed rat infarct caused by early and late coronary artery reperfusion.

S L Hale1, R A Kloner.   

Abstract

Topographic changes in the completely healed (6 weeks) left ventricle of the rat, caused by early (30 minutes) and delayed (90 minutes) coronary artery reperfusion, were examined. With early reperfusion the extent of the scar, as a percentage of left ventricular (LV) circumference, was reduced compared to the extent of the scar in rats with permanent occlusion (27 +/- 3% vs 42 +/- 2%, p less than 0.01). Early reperfusion also preserved LV topography by preventing dilation of the LV cavity and thinning of the healed free wall. Late reperfusion (90 minutes) did not reduce the extent of the scar (35 +/- 3% vs 42 +/- 2% of LV circumference, p = NS) or prevent dilation of the LV cavity compared with permanent occlusion. However, the healed free wall/noninfarcted septum ratio was significantly greater in rats with late reperfusion than in those with permanent occlusion (0.98 +/- 0.06 vs 0.73 +/- 0.07, p less than 0.05). Thus early reperfusion completely inhibited scar thinning and dilation of the LV cavity, maintaining normal LV topography. Late reperfusion, too late to reduce infarct size, still contributed to improved healing of the myocardium by resulting in a thicker scar.

Entities:  

Mesh:

Year:  1988        PMID: 3195435     DOI: 10.1016/0002-8703(88)90736-3

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  The Open-Artery Hypothesis: An Overview.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Late reopening of an occluded infarct related artery improves left ventricular function and long term clinical outcome.

Authors:  F Piscione; G Galasso; G De Luca; G Marrazzo; G Sarno; O Viola; D Accardo; M Chiariello
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

4.  Immunohistochemical study of fibronectin in experimental myocardial infarction.

Authors:  W Casscells; H Kimura; J A Sanchez; Z X Yu; V J Ferrans
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

Review 5.  Congestive heart failure. New frontiers.

Authors:  W W Parmley; K Chatterjee; G S Francis; B G Firth; R A Kloner
Journal:  West J Med       Date:  1991-04

6.  Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion.

Authors:  A A Knowlton; C M Connelly; G M Romo; W Mamuya; C S Apstein; P Brecher
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

7.  Effects of Late Coronary Artery Reperfusion on Left Ventricular Remodeling Persist for 10 Weeks After Experimental Rat Myocardial Infarction and Are Associated with Improved Survival.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1994       Impact factor: 2.300

8.  Effects of late reperfusion on infarct expansion and infarct healing in conscious rats.

Authors:  M Morita; S Kawashima; M Ueno; A Kubota; T Iwasaki
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

Review 9.  Effect of coronary collateral circulation on myocardial ischemia and ventricular dysfunction.

Authors:  S Sasayama
Journal:  Cardiovasc Drugs Ther       Date:  1994-05       Impact factor: 3.727

10.  Transplantation of genetically engineered cardiac fibroblasts producing recombinant human erythropoietin to repair the infarcted myocardium.

Authors:  Emil Ruvinov; Orna Sharabani-Yosef; Arnon Nagler; Tom Einbinder; Micha S Feinberg; Radka Holbova; Amos Douvdevani; Jonathan Leor
Journal:  Fibrogenesis Tissue Repair       Date:  2008-11-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.